Celanese (NYSE:CE – Get Free Report) is anticipated to issue its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of $1.28 per share and revenue of $2.5127 billion for the quarter. Celanese has set its Q3 2025 guidance at 1.100-1.400 EPS.Individuals can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Friday, November 7, 2025 at 9:00 AM ET.
Celanese (NYSE:CE – Get Free Report) last announced its quarterly earnings results on Monday, August 11th. The basic materials company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.38 by $0.06. Celanese had a positive return on equity of 10.48% and a negative net margin of 16.30%.The business had revenue of $2.53 billion for the quarter, compared to the consensus estimate of $2.50 billion. During the same quarter last year, the business posted $2.38 EPS. The business’s revenue was down 4.5% on a year-over-year basis. On average, analysts expect Celanese to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.
Celanese Price Performance
Shares of NYSE CE opened at $37.34 on Wednesday. Celanese has a 1-year low of $35.71 and a 1-year high of $102.00. The company has a debt-to-equity ratio of 2.22, a current ratio of 2.05 and a quick ratio of 1.22. The business’s fifty day moving average price is $42.99 and its two-hundred day moving average price is $49.07. The firm has a market capitalization of $4.09 billion, a PE ratio of -2.52, a P/E/G ratio of 1.86 and a beta of 1.13.
Celanese Dividend Announcement
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on CE shares. Alembic Global Advisors set a $60.00 target price on Celanese in a research report on Monday, August 25th. KeyCorp cut their target price on Celanese from $77.00 to $70.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 13th. Cfra Research raised Celanese to a “moderate sell” rating in a research note on Tuesday, August 12th. JPMorgan Chase & Co. cut their target price on Celanese from $47.00 to $40.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. Finally, Bank of America cut their target price on Celanese from $59.00 to $57.00 and set a “buy” rating on the stock in a research note on Tuesday, October 14th. Seven investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Celanese has an average rating of “Hold” and an average target price of $56.11.
Get Our Latest Analysis on Celanese
Insiders Place Their Bets
In other news, Director Timothy Go bought 1,039 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was acquired at an average price of $46.25 per share, with a total value of $48,053.75. Following the completion of the purchase, the director directly owned 4,415 shares of the company’s stock, valued at $204,193.75. This represents a 30.78% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Celanese
Institutional investors and hedge funds have recently modified their holdings of the stock. Geneos Wealth Management Inc. raised its position in shares of Celanese by 111.1% during the second quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company’s stock worth $28,000 after purchasing an additional 270 shares during the period. Smartleaf Asset Management LLC raised its position in shares of Celanese by 100.0% during the second quarter. Smartleaf Asset Management LLC now owns 662 shares of the basic materials company’s stock worth $38,000 after purchasing an additional 331 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Celanese by 144.9% during the second quarter. EverSource Wealth Advisors LLC now owns 1,276 shares of the basic materials company’s stock worth $71,000 after purchasing an additional 755 shares during the period. Headlands Technologies LLC acquired a new stake in shares of Celanese during the second quarter worth $180,000. Finally, Vident Advisory LLC acquired a new stake in shares of Celanese during the second quarter worth $222,000. 98.87% of the stock is owned by institutional investors and hedge funds.
About Celanese
Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
Read More
- Five stocks we like better than Celanese
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- ETF Screener: Uses and Step-by-Step Guide
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- Asset Allocation Strategies in Volatile Markets
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.
